We seek to contribute to the growing body of knowledge surrounding POSTN-integrin signaling and its implications for HCC patients, ultimately contributing to the development of innovative strategies for diagnosis and treatment in this challenging disease. The gene discussed is POSTN; the disease is hepatocellular carcinoma.